GFRA1 and breast carcinoma: Additionally, co-overexpression of RET-GFRα1 was inversely correlated with expression of basal markers and positively correlated with enhanced cell proliferation and survival of ER+ cells (143), suggesting that RET pathway activity may be a novel target in this breast cancer subtype.